| Institute |
|---|
| University of Illinois Chicago |
| SKU: | 156378 |
|---|---|
| Product description: | Lymphatic filariasis, caused by Brugia malayi and others, affects more than 120 million people worldwide causing major public health problems especially in the tropics. Brugia malayi – ALT-2 protein is abundantly synthesized in the infective stages of the parasite and believed to play a major role in the transmission and infectivity of the filarial parasite. Bm-alt-2 has several important characteristics of a vaccine candidate. These include high levels of expression in the infective larval stages presenting as an abundant target for the immune system and more importantly there is no known homolog in the mammalian species. |
| Alternate name: | ALT |
| Conjugation: | Unconjugated |
| Immunogen: | Recombinant Bm-ALT-2 protein |
| Cat. #: | 156378 |
|---|---|
| Unit size: | 100 ug |
| Application: | WB ; FACS ; ELISA |
| Target: | Abundant Larval Transcript-2 |
| Host: | Jird |
| Class: | Polyclonal |
| Target background: | Lymphatic filariasis, caused by Brugia malayi and others, affects more than 120 million people worldwide causing major public health problems especially in the tropics. Brugia malayi – ALT-2 protein is abundantly synthesized in the infective stages of the parasite and believed to play a major role in the transmission and infectivity of the filarial parasite. Bm-alt-2 has several important characteristics of a vaccine candidate. These include high levels of expression in the infective larval stages presenting as an abundant target for the immune system and more importantly there is no known homolog in the mammalian species. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Thirugnanam et al. 2007. Exp Parasitol. 116(4):483-91. PMID: 17442307. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.